Suppr超能文献

白蛋白在肝硬化中的作用:从一名住院医师的视角

Role of albumin in cirrhosis: from a hospitalist's perspective.

作者信息

Walayat Saqib, Martin Daniel, Patel Jaymon, Ahmed Umair, N Asghar Muhammad, Pai Aparna U, Dhillon Sonu

机构信息

Department of Internal Medicine, University of Illinois Peoria Campus, OSF Saint Francis Medical Center, Peoria, IL, USA.

Department of Gastroenterology and Hepatology, University of Illinois Peoria Campus, OSF Saint Francis Medical Center, Peoria, IL, USA.

出版信息

J Community Hosp Intern Med Perspect. 2017 Mar 31;7(1):8-14. doi: 10.1080/20009666.2017.1302704. eCollection 2017 Jan.

Abstract

Albumin, a negatively charged globular protein encoded on chromosome 4, is one of the most abundant proteins in the plasma and accounts for approximately 75% of plasma oncotic pressure. The role of albumin in the management of various disease states has shown to be beneficial historically. Low serum albumin is a predictor of mortality and poor outcomes. In cirrhotics undergoing paracentesis, albumin infusion prevents rapid re-accumulation of ascitic fluid while simultaneously decreasing the risk of post-paracentesis related circulatory dysfunction. Additionally, albumin is utilized in patients with hepatorenal syndrome (HRS) and spontaneous bacterial peritonitis (SBP). Overall, albumin appears to be an effective pharmacological agent in the management of cirrhosis and its complications.

摘要

白蛋白是一种由4号染色体编码的带负电荷的球状蛋白,是血浆中含量最丰富的蛋白质之一,约占血浆胶体渗透压的75%。从历史上看,白蛋白在各种疾病状态的管理中所起的作用已被证明是有益的。低血清白蛋白是死亡率和不良预后的一个预测指标。在接受腹腔穿刺术的肝硬化患者中,输注白蛋白可防止腹水迅速重新积聚,同时降低腹腔穿刺术后相关循环功能障碍的风险。此外,白蛋白还用于肝肾综合征(HRS)和自发性细菌性腹膜炎(SBP)患者。总体而言,白蛋白似乎是治疗肝硬化及其并发症的一种有效药物。

相似文献

1
Role of albumin in cirrhosis: from a hospitalist's perspective.
J Community Hosp Intern Med Perspect. 2017 Mar 31;7(1):8-14. doi: 10.1080/20009666.2017.1302704. eCollection 2017 Jan.
2
Role of human albumin in the management of complications of liver cirrhosis.
J Clin Exp Hepatol. 2014 Dec;4(4):302-11. doi: 10.1016/j.jceh.2014.08.007. Epub 2014 Sep 19.
3
[The use of albumin infusion in decompensated liver cirrhosis].
Ugeskr Laeger. 2002 Feb 25;164(9):1196-202.
4
Albumin in Cirrhosis: More Than a Colloid.
Curr Treat Options Gastroenterol. 2019 Jun;17(2):231-243. doi: 10.1007/s11938-019-00227-4.
7
Clinical indications for the albumin use: still a controversial issue.
Eur J Intern Med. 2013 Dec;24(8):721-8. doi: 10.1016/j.ejim.2013.05.015. Epub 2013 Jun 20.
8
Long-term albumin infusion in decompensated cirrhosis: A review of current literature.
World J Hepatol. 2021 Apr 27;13(4):421-432. doi: 10.4254/wjh.v13.i4.421.
9
Evaluation of different therapeutic approaches for spontaneous bacterial peritonitis.
Arab J Gastroenterol. 2012 Jun;13(2):65-70. doi: 10.1016/j.ajg.2012.06.003. Epub 2012 Jul 5.

引用本文的文献

1
Timely Albumin Infusion May Improve Resource Utilization in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis.
Biomed Res Int. 2024 Jun 8;2024:6673823. doi: 10.1155/2024/6673823. eCollection 2024.
2
MH-STRALP: A scoring system for prognostication in patients with upper gastrointestinal bleeding.
World J Gastrointest Surg. 2024 Mar 27;16(3):790-806. doi: 10.4240/wjgs.v16.i3.790.
4
Parenclitic Network Mapping Identifies Response to Targeted Albumin Therapy in Patients Hospitalized With Decompensated Cirrhosis.
Clin Transl Gastroenterol. 2023 Jun 1;14(6):e00587. doi: 10.14309/ctg.0000000000000587.
5
Rifaximin Improves Liver Functional Reserve by Regulating Systemic Inflammation.
J Clin Med. 2023 Mar 13;12(6):2210. doi: 10.3390/jcm12062210.
7
Gluing blood into gel by electrostatic interaction using a water-soluble polymer as an embolic agent.
Proc Natl Acad Sci U S A. 2022 Oct 18;119(42):e2206685119. doi: 10.1073/pnas.2206685119. Epub 2022 Oct 10.
8
Infection and Liver Cirrhosis - A Retrospective, Cohort Study.
Clin Exp Gastroenterol. 2021 Jun 3;14:229-235. doi: 10.2147/CEG.S308862. eCollection 2021.
10
Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension.
GE Port J Gastroenterol. 2020 Dec;28(1):5-12. doi: 10.1159/000507894. Epub 2020 Jun 9.

本文引用的文献

1
Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study.
J Hepatol. 2013 Dec;59(6):1184-92. doi: 10.1016/j.jhep.2013.07.020. Epub 2013 Jul 19.
4
Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials.
Clin Gastroenterol Hepatol. 2013 Feb;11(2):123-30.e1. doi: 10.1016/j.cgh.2012.11.007. Epub 2012 Nov 22.
6
The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis.
Clin Gastroenterol Hepatol. 2012 Oct;10(10):1169-75. doi: 10.1016/j.cgh.2012.06.027. Epub 2012 Jul 16.
7
Hyponatremia in cirrhosis and end-stage liver disease: treatment with the vasopressin V₂-receptor antagonist tolvaptan.
Dig Dis Sci. 2012 Nov;57(11):2774-85. doi: 10.1007/s10620-012-2276-3. Epub 2012 Jun 26.
8
Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study.
J Hepatol. 2012 Oct;57(4):759-65. doi: 10.1016/j.jhep.2012.06.013. Epub 2012 Jun 23.
10
How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure.
World J Gastroenterol. 2011 Aug 14;17(30):3479-86. doi: 10.3748/wjg.v17.i30.3479.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验